August 11, 2008 / 2:55 PM / 11 years ago

Toronto stock index drops on materials, healthcare

TORONTO, Aug 11 (Reuters) - Toronto Stock Exchange’s main index opened lower on Monday, weighed down by materials stocks while news relating to Cardiome Pharma Corp’s COM.TO Kynapid heart treatment was also a drag on sentiment.

Shortly after the open, the S&P/TSX composite index .GSPTSE was down 60.67 points, or 0.5 percent, at 13,281.07, with six of its 10 main groups lower.

The resource-laden materials sector sank 2.9 percent, in line with a slump in the price of bullion. Yamana Gold (YRI.TO) slipped 28 Canadian cents, or 2.5 percent, to C$10.81.

The healthcare group slid 9 percent. Shares of Cardiome slid 27 percent to C$9.37 after it and Astellas Pharma US, Inc. (4503.T) announced the receipt of an FDA approvable letter for Kynapid.

Cardiome said the FDA requested additional information, including a safety update from ongoing or completed studies of vernakalant, which is used in the treatment of atrial fibrillation or abnormal heart rhythm. ($1=$1.07 Canadian) (Reporting by Jennifer Kwan; Editing by Bernadette Baum)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below